In-Person Access Only | 8.0 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
Total Health's 2026 Best of ASCO® Boston Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Conference Agenda
Saturday, August 8, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Welcome and Opening Remarks
Thierry Alcindor, MD, MSc | Dana-Farber Cancer Institute
8:40 AM
Colorectal Cancer
Daniel Lin, MD | Thomas Jefferson University
9:10 AM
Non-Colorectal Cancer
Bruno Bockorny, MD, FACP | Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast presented by Regeneron - Immunotherapy in Practice: A Compelling Case-Based Discussion Examining Actual Patients with Advanced NSCLC
Raghava Induru, MD | Levine Cancer Institution, Advocate Health
10:40 AM
Prostate Cancer
Kathleen Mahoney, MD | Beth Israel Deaconess Medical Center
11:10 AM
Non-Prostate Cancer
Brad McGregor, MD | Dana-Farber Cancer Institute
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch presented by Incyte - Monjuvi + Rituximab & Lenalidomide: The First and Only CD19- and CD20-targeted Immunotherapy Combination for 2L+ Follicular Lymphoma Patients
Charles Farber, MD | Carol G. Simon Cancer Center
12:40 PM
Housekeeping and Survey
12:50 PM
Leukemia
Courtney DiNardo, MD, MSCE | MD Anderson
1:20 PM
Lymphoma
Henry Fung, MD | Temple University
1:50 PM
Head and Neck Cancer
Barbara Burtness, MD | Yale Cancer Center
2:20 PM
Sarcomas and Rare Cancers
Thierry Alcindor, MD, MSc | Dana-Farber Cancer Institute
2:50 PM
Adjourn
Sunday, August 9, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Welcome and Opening Remarks
Beverly Moy, MD, MPH | Massachusetts General Hospital
8:40 AM
Small Cell Lung Cancer
Pasi Jänne, MD, PhD|Dana-Farber Cancer Institute
9:10 AM
Non-Small Cell Lung Cancer
Ana Velázquez Mañana, MD, MSc, FASCO | University of California San Francisco
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast presented by Pfizer
10:40 AM
Multiple Myeloma
Philip McCarthy, MD | Roswell Park Comprehensive Cancer Center
11:10 AM
Melanoma
Ryan Sullivan, MD | Massachusetts General Hospital
11:40 AM
Gynecological Oncology
Ramez Eskander, MD | Moores Cancer Center
12:10 PM
Lunch and Exhibits
12:25 PM
Non-CME Lunch presented by Abbvie
1:10 PM
Survivorship
Stacy Wentworth, MD | Duke University School of Medicine
1:40 PM
Early-Stage Breast Cancer
Beverly Moy, MD, MPH | Massachusetts General Hospital
2:10 PM
Metastatic Breast Cancer
Adrienne Waks, MD | Dana-Farber Cancer Institute
2:40 PM
Adjourn
Agenda Subject To Change. All times are EST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 8.00 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 8.00 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program